Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Werewolf Therapeutics Inc have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a 470.78% increase from the last price of 2.19.
High | 584.9% | 15.00 |
Med | 470.8% | 12.50 |
Low | 265.3% | 8.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -32.13% |
Average growth rate | +63.27% |
More ▼
Revenue history & estimates in USD
Average growth rate | -24.52% |
Average growth rate | +21.60% |
More ▼